Keywords Aortic valve replacement Á MRI guidance Á Minimally invasive aortic valve Purpose Percutaneous valve replacements are new procedures presently being evaluated in clinical trials. Transapical aortic valve replacement, compared with the percutaneous transfemoral approach, provides a direct and short access to the native valve and permits precise implantation of conventional prosthesis that have a known durability and proven success rate. Both minimally invasive approaches reduce trauma and shorten patient recovery time. Many medical experts predict that these new procedures could revolutionize valve replacement. Use of real-time MRI (rtMRI) allows physicians to monitor the progress of the procedure and also provides the ability to immediately assess the results, such as ventricular and valvular function, and myocardial perfusion. Our team has successfully performed aortic valve replacements in a large animal model using the transapical approach with rtMRI guidance. The procedure poses technical challenges regarding to the MRI environment, stent design, optimum bioprosthesis placement and durability. Methods All the instruments and materials are MRI safe and compatible. The prostheses used in the experiments are commercially available (21-27 mm in diameter) stentless bioprosthetic valves (Toronto SPV, St. Jude Medical, Minneapolis, MN, or Freestyle aortic root bioprosthesis, Medtronic Inc, Minneapolis, MN). The prostheses were sutured inside of analogous sized platinum-iridium balloon-expandable (BE) stents (Cheatham Platinum, NuMed, Hopkinton, NY) or custom designed nitinol self-expanding (SE) stents. Because the aortic valve lies in close proximity to both the mitral valve and the coronary ostia, the position and orientation of the implanted valve is critical. To precisely orient the prosthesis a passive marker was affixed to the stents. For deploying the BE stent, a two stage balloon-tipped catheter (NuMed, 25-30 mm OD, 50 mm long) was used. For proper deployment of the SE stent, a special snare catheter was developed to hold the bioprosthesis until final placement. The bioprosthesis and the stent were circumferentially compressed and inserted in a custom designed delivery device that fits in a 10-12 mm trocar (Ethicon surgical Inc, Somerville, NJ). Thirty-eight animals underwent transapical aortic valve replacement under rtMRI on the beating heart. Following 18 short term survival feasibility experiments; Ten animals underwent valve replacement with balloon-expandable stented prosthesis and 10 animals were implanted with a self-expanding stented prosthesis.. All the experiments were performed under protocols approved by the NIH Animal Care and Use committee. A 1.5T Siemens Espree scanner with a fully interactive real time interactive sequencing was used. Standard MRI sequences were used for preoperative surgical planning -obtain heart orientation, locate the native valve annulus and the origin of coronary arteries -and post placement evaluation. Three imaging planes were selected for real time imaging. Two of these provide long axis views of the left ventricle, right coronary artery origin (digitally marked) and left anterior descending coronary artery origin (also digitally marked). The third plane provides an axial view of the aortic valve. The long-axis and short axis views were interactively modified to show the path of the delivery device. The surgeon viewed the realtime imaging on a projection screen while manipulating the deployment device within the animal in the magnet. The surgeon was in contact with the scanner operator by means of headphone (Magnacoustics, Atlantic Beach, NY) to request changes in the imaging planes as needed. After valve placement, the trocar was removed and the heart apex closed. Post implantation images were acquired to confirm the position of the prosthesis and the valvular and heart functions. The follow-up MRI scans and transthoracic echocardiograms were acquired for the long term survival animals at 1, 3 and 6 months. A histopathology evaluation of the heart at 6 months was also performed. Results rtMRI provides excellent visualization for intraoperative guidance of aortic valve replacement on the beating heart using both balloonexpandable and self-expanding stented prosthesis. In Fig. 1 , three steps of the self-expanding stented prosthesis deployment are presented.
Purpose
Percutaneous valve replacements are new procedures presently being evaluated in clinical trials. Transapical aortic valve replacement, compared with the percutaneous transfemoral approach, provides a direct and short access to the native valve and permits precise implantation of conventional prosthesis that have a known durability and proven success rate. Both minimally invasive approaches reduce trauma and shorten patient recovery time. Many medical experts predict that these new procedures could revolutionize valve replacement. Use of real-time MRI (rtMRI) allows physicians to monitor the progress of the procedure and also provides the ability to immediately assess the results, such as ventricular and valvular function, and myocardial perfusion. Our team has successfully performed aortic valve replacements in a large animal model using the transapical approach with rtMRI guidance. The procedure poses technical challenges regarding to the MRI environment, stent design, optimum bioprosthesis placement and durability. Methods All the instruments and materials are MRI safe and compatible. The prostheses used in the experiments are commercially available (21-27 mm in diameter) stentless bioprosthetic valves (Toronto SPV, St. Jude Medical, Minneapolis, MN, or Freestyle aortic root bioprosthesis, Medtronic Inc, Minneapolis, MN). The prostheses were sutured inside of analogous sized platinum-iridium balloon-expandable (BE) stents (Cheatham Platinum, NuMed, Hopkinton, NY) or custom designed nitinol self-expanding (SE) stents. Because the aortic valve lies in close proximity to both the mitral valve and the coronary ostia, the position and orientation of the implanted valve is critical. To precisely orient the prosthesis a passive marker was affixed to the stents. For deploying the BE stent, a two stage balloon-tipped catheter (NuMed, 25-30 mm OD, 50 mm long) was used. For proper deployment of the SE stent, a special snare catheter was developed to hold the bioprosthesis until final placement. The bioprosthesis and the stent were circumferentially compressed and inserted in a custom designed delivery device that fits in a 10-12 mm trocar (Ethicon surgical Inc, Somerville, NJ). Thirty-eight animals underwent transapical aortic valve replacement under rtMRI on the beating heart. Following 18 short term survival feasibility experiments; Ten animals underwent valve replacement with balloon-expandable stented prosthesis and 10 animals were implanted with a self-expanding stented prosthesis.. All the experiments were performed under protocols approved by the NIH Animal Care and Use committee. A 1.5T Siemens Espree scanner with a fully interactive real time interactive sequencing was used. Standard MRI sequences were used for preoperative surgical planning -obtain heart orientation, locate the native valve annulus and the origin of coronary arteries -and post placement evaluation. Three imaging planes were selected for real time imaging. Two of these provide long axis views of the left ventricle, right coronary artery origin (digitally marked) and left anterior descending coronary artery origin (also digitally marked). The third plane provides an axial view of the aortic valve. The long-axis and short axis views were interactively modified to show the path of the delivery device. The surgeon viewed the realtime imaging on a projection screen while manipulating the deployment device within the animal in the magnet. The surgeon was in contact with the scanner operator by means of headphone (Magnacoustics, Atlantic Beach, NY) to request changes in the imaging planes as needed. After valve placement, the trocar was removed and the heart apex closed. Post implantation images were acquired to confirm the position of the prosthesis and the valvular and heart functions. The follow-up MRI scans and transthoracic echocardiograms were acquired for the long term survival animals at 1, 3 and 6 months. A histopathology evaluation of the heart at 6 months was also performed. Results rtMRI provides excellent visualization for intraoperative guidance of aortic valve replacement on the beating heart using both balloonexpandable and self-expanding stented prosthesis. In Fig. 1 , three steps of the self-expanding stented prosthesis deployment are presented.
Images acquired post-placement confirmed the optimum positions of the prostheses and the valvular and heart function. Gated cine MRI revealed excellent myocardial function after valve implantation in both long and short-axis views. The phase-contrast CINE MR images confirmed good systolic flow with excellent valve leaflet opening and no evidence of diastolic regurgitant flow, or paravalvular leak. The perfusion results confirmed adequacy of blood flow at the tissue level, indicating proper valve positioning with respect to the coronary ostia. The passive marker on the stents is a good indicator of the valve orientation in MRI. But because of the heart motion, the artifact yielded by the passive marker is not always well visible in the realtime beating heart MR images. We tested an active marker that gives improved information of stent orientation. The active marker consists of small loop coil antenna affixed on outer tube of delivery device. The histopathology reports at 6 month verified that the implanted both balloon-expandable and self-expanding stented prosthesis appeared to be properly seated in the aortic root. Analysis of biocompatibility of both stents proved to be biocompatible. In Figure 2 a cross section of bioprosthesis shows that the prosthetic commissures were incorporated with neointimal growth continuous with the native Fig. 1 Self-expanding stented prosthesis deployment; a -stented prosthesis in delivery device, b -stented prosthesis partially deployed, c -stented prosthesis fully deployed. leaflet commissures. Stent struts adjacent to the prosthetic commissures were also covered with neointima. Conclusion rtMRI provides better visualization of the heart and landmarks needed for the aortic valve implantation comparatively with fluoroscopy and echocardiography. Long term results demonstrated stability of the implants with the preservation of myocardial function over time. The passive or active marker on the stents serves a good indicator of the valve orientation in MRI. Implantation of bioprosthesis with balloon expandable stent poses more challenges, regarding valve orientation, migration and precise positioning. Optimum design of delivery device can improve placement precision. Implantation of bioprosthesis valve with selfexpanding stent is more precise and predictable. To prevent early unexpected jumping of the bioprosthesis, a special snare catheter was developed. Also this snare catheter can retract a partially deployed bioprosthesis inside the delivery device. 
Electrophysiological map is effective in realizing more accurate Minimally Invasive Arrhythmia Surgery. The mapping system requires tracking of an electrode on the epicardium. Image based epicardial motion tracking method was reported before. But, it needs a separate tracking system for indentifying the position and orientation of electrode because it focused on the data integration of electrophysiological map and endoscopic image. This paper proposes a new method of tracking an electrode and epicardium simultaneously with endoscopic image. Methods Positions of four blue optical markers and electrode array are tracked through a simplified ConDensation algorithm. The orientation of electrode array is calculated from the positions of markers and the extracted line of electrode array using Hough transform. All the data are transformed and processed on the marker-based coordinates system. Tracking error caused by the posture of endoscopy is calibrated using the relationship between posture and error obtained from simulation. Results Mean errors in position and orientation tracking accuracy are 0.41 mm and 0.49degree respectively. Tracking speed is nearly constant 22 frames per second. No problem showed in tracking an electrode in laboratory test and in vivo experiment.
Conclusion
Image based tracking method for localizing an electrode on the moving epicardium was proposed. Tracking accuracy and its usefulness was proved to be acceptable through a performance test and in vivo experiment. Our method contributes three benefits: a simplified system configuration, no need of registration of information onto the preoperative model and an effective information display with endoscopic image. Keywords Magnetic resonance imaging Á Fetal heart Á Congenital disorder Á Prenatal diagnosis Á Non-invasive Purpose Various diagnostic approaches exist for the exploration of fetal heart disease. Today, imaging modalities have an integral part in prenatal diagnostics; i.e. conventional echocardiography and magnetic resonance imaging (MRI). Although MRI shows superior soft tissue contrast, fetal cardiac imaging for prenatal heart function assessment is performed with ultrasonography in clinical routine. This is explained by insufficient visibility of moving structures with MRI. Motion artifacts, which occur when imaging moving organs with MRI, may be avoided with triggered or fast image acquisition. In vivo fetal cardiac MRI still lacks a feasible triggering concept, which is safe for both fetus and mother and allows reliable and fast detection of fetal heart phases. Methods In fetal cardiac imaging, electrocardiographic (ECG) MRI triggering is associated with unjustifiable risks. Fetal ECG requires a cabled electrode to be invasively placed on the fetus's head, through wich currents may be induced from the MRI and shock the fetus and the mother. Fetal cardiac imaging can also be accomplished by reducing the duration of image acquisition with fast gradient systems in combination with sequence optimization and parallel imaging. However, the design of fast gradient systems is limited by the risk of peripheral nervous stimulation and image quality will typically reduce with faster sequences. The advantage of increased data acquisition rates is linked directly to a decline in SNR. Results In our approach the fetal heart movement is measured with ultrasound sensors, which are connected to a receiver with a wireless MR-compatible signal transducer. After signal processing and noise reduction, the data is sent to a fetal monitor for visualization and to the MR-system for image triggering (Fig. 1 ). The prototype monitor system is based on a commercially available CTG monitor (Philips, Avalon FM 50), in combination with a modified wireless transducer system (Philips, Avalon CTS) and a modified receiver (Philips, Avalon CTS). For security reasons this setup allows measuring fetal heartbeat and uterine contractions, while only the first is relevant to Fig. 2 Histopathologic results; a-whole mount of bioprosthesis section (level of prosthetic leaf cusps); b and c -close-up images of bioprhosthesis section shows neointimal incorporation of a prosthetic commissure and stent. Fig. 1 Data is sent to a fetal monitor for visualization and to the MR-system for image triggering trigger the MRI system. The modification of the transducers specifically targets the electronic components. These components include fixtures, magnetic switches, coils, capacitors and accumulators; all of which were replaced with adequate, non-ferromagnetic, commercial and custom-built substitutes, such as the Toco-Sensor (Senstech AG, Switzerland). In addition, the system was enhanced with a signal router which broadcasted the signal to the fetal monitor and the MR-controller software for further processing. The software filters the noise induced by the MRI's RF-generator during image acquisition (Fig. 2) . To test MR-compatibility, the magnetic attraction was measured with ASTM F2052 in a Philips 1.5 Tesla GryroScan. The test environment (Fig. 3) was set up in an open high-field MRI system (Philips Panorama HFO 1T). The measurement setup includes a fetal heartbeat simulator based on a roll-pump system (World of Medicine AG) which generates a rhythmic flow at approximately 190 bpm.
The artifact of the transducers in a T2FSE sequence (TA 1.5 s, FA 90°, TR 500 ms, TE 20 ms) is approximately 7 cm for both. The prototype is based on wireless data transmission at 900 MHz carrier frequency and does not interfere with MR-relevant frequencies (ca. 42 MHz). In none of the investigated sequences a significant reduction of SNR could be detected, so that we can preclude a negative influence on image quality. According to ASTM F2052 the magnetic attraction revealed an object deviation of 21°at 2.4 T/m at a weight of 107 g for the ultrasound-transducer and an object deviation of 18°at 2.4 T/m at a weight of 105 g for the ultrasound-transducer and thereby proves MR-compatibility. The filtering-algorithm, based on Fourier transformation, allows precise distinguishability of MR-induced noise and the simulated heartbeat signal (Fig. 2) . The cleansed signal allows MR triggering through the designated triggering interface of the MRI. The MRI software identified the simulated heartbeat as valid triggering signal at approximately 190 bpm.
We hereby conclude that the herein presented ultrasound-based transducer of the MRI compatible CTG monitoring prototype is practicable approach to measure fetal heartbeat in the MRI environment during image acquisition. This would allow triggering of the MRI to enable sequence-independent fetal heart imaging. 
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